7 November 2018 - FDA released on Tuesday an open source code app that can be used to collect real-world data directly from patients, including from mobile devices.
The MyStudies app is a digital platform that users can adapt to collect data from a “variety of sources, such as electronic health records, claims and billing activities, product and disease registries, as well as patient-generated data including in home-use settings, as well as data gathered from other sources, such as mobile devices,” according to an FDA announcement. The app can be customised and used to administer questionnaires assessing patient-reported outcomes, symptom scales or patient reports of medication use.
“Our hope is that the collection of more real world data directly from patients, using a secure app, will lead to more efficient product development and assist with safety monitoring,” FDA Commissioner Scott Gottlieb said.